Constellation Brands to Present at the 2023 Morgan Stanley Global Consumer and Retail Conference on December 5, 2023 30-11-2023, 04:30

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical stage RXR agonist for treatment of normal aging-related neurodegeneration, at the FASEB Science Research Conference on Cellular and Molecular Mechanisms of Brai 18-09-2024, 22:07

Synaptics Strengthens Leadership Team with Addition of Lori 7-02-2023, 16:09